Status:
COMPLETED
Retroclavicular Approach to Infraclavicular Block
Lead Sponsor:
Antalya Training and Research Hospital
Conditions:
Bupivacaine
Eligibility:
All Genders
18-65 years
Brief Summary
In this study, the primary objective was to estimate the minimum effective volume of bupivacaine 0.5% resulting in successful block in 50% of patients (MEV50) for ultrasound-guided retroclavicular app...
Detailed Description
Two rules were used to stop the study. First stopping rule was a fixed-sample-size. The investigators used an up-and-down method to estimate the threshold for an all-or-none response for present study...
Eligibility Criteria
Inclusion
- patients who received infraclavicular brachial plexus block for elective elbow, forearm, wrist, or hand surgery
- American Society of Anesthesiologists class I, II or III
Exclusion
- patients \<18 years old
- \>65 years old
- body mass index (BMI) \<20 or \>35 kg/m2
- inability to provide written informed consent
- refusal of regional anesthesia
- pregnancy
- contraindication for regional anesthesia
Key Trial Info
Start Date :
January 8 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2018
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03472911
Start Date
January 8 2018
End Date
March 15 2018
Last Update
May 3 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antalya Training and Research hospital
Antalya, Turkey (Türkiye), 07100